Savitz,Adam J., Xu,Haiyan, Gopal,Srihari, Nuamah,Isaac, Mathews,Maju, & Soares,Bernardo. (2019). Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies.
Chicago Style CitationSavitz,Adam J., Xu,Haiyan, Gopal,Srihari, Nuamah,Isaac, Mathews,Maju, and Soares,Bernardo. Efficacy and Safety of Paliperidone Palmitate 3-month Formulation in Latin American Patients With Schizophrenia: A Subgroup Analysis of Data From Two Large Phase 3 Randomized, Double-blind Studies. 2019.
MLA CitationSavitz,Adam J., et al. Efficacy and Safety of Paliperidone Palmitate 3-month Formulation in Latin American Patients With Schizophrenia: A Subgroup Analysis of Data From Two Large Phase 3 Randomized, Double-blind Studies. 2019.